疾病
癌症
机制(生物学)
药物开发
发病机制
医学
生物
生物信息学
神经科学
药品
免疫学
病理
内科学
精神科
哲学
认识论
作者
Xueqing Yang,Jinlian Dai,Chenglong Wu,Zongliang Liu
出处
期刊:Mini-reviews in Medicinal Chemistry
[Bentham Science]
日期:2023-12-01
卷期号:24 (10): 983-1000
标识
DOI:10.2174/0113895575263108231031132404
摘要
There is growing epidemiologic evidence of an inverse association between cancer and AD. In addition, both cell survival and death are regulated by the same signaling pathways, and their abnormal regulation may be implicated in the occurrence and development of cancer and AD. Research shows that there may be a common molecular mechanism between cancer and AD. This review will discuss the role of GSK3, DAPK1, PP2A, P53 and CB2R in the pathogenesis of cancer and AD and describe the current research status of drug development based on these targets.
科研通智能强力驱动
Strongly Powered by AbleSci AI